Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Ecotoxicol Environ Saf ; 233: 113317, 2022 Mar 15.
Article in English | MEDLINE | ID: mdl-35182796

ABSTRACT

Antimony (Sb) pollution has increased health risks to humans as a result of extensive application in diverse fields. Exposure to different levels of Sb and its compounds will directly or indirectly affect the normal function of the human body, whereas limited human health data and simulation studies delay the understanding of this element. In this review, we summarize current research on the effects of Sb on human health from different perspectives. First, the exposure pathways, concentration and excretion of Sb in humans are briefly introduced, and several studies have revealed that human exposure to high levels of Sb will cause higher concentrations in body tissues. Second, interactions between Sb and biomolecules or other nonbiomolecules affected biochemical processes such as gene expression and hormone secretion, which are vital for causing and understanding health effects and mechanisms. Finally, we discuss the different health effects of Sb at the biological level from small molecules to individual. In conclusion, exposure to high levels of Sb compounds will increase the risk of disease by affecting different cell signaling pathways. In addition, the appropriate form and dose of Sb contribute to inhibit the development of specific diseases. Key challenges and gaps in toxicity or benefit effects and mechanisms that still hinder risk assessment of human health are also identified in this review. Systematic studies on the relationships between the biochemical process of Sb and human health are needed.


Subject(s)
Antimony , Environmental Pollution , Antimony/analysis , Humans
2.
Biomaterials ; 192: 51-61, 2019 02.
Article in English | MEDLINE | ID: mdl-30419395

ABSTRACT

Blood is a treasure trove whose constituents have attracted increasing attention for use in understanding and controlling disease. However, the functions of blood, especially with regard to its composition at the nanoscale, remain largely unknown. Inspired by exosomes and lipoproteins, the present work isolated and characterized biotic nanodiscs from human blood (BNHBs) using multiple techniques. The isolated BNHBs had diameters of 10-30 nm and a thicknesses of approximately 2.9 nm. The BNHB concentration in blood peaked at 34.5 ±â€¯5.19 mg/mL (20-fold higher than that of high-density lipoproteins and exosomes). BNHBs had high biocompatibility, facile cell internalization and strong biological control of pulmonary fibrosis. The BNHBs were hybrids of many metalloproteins and metabolites and contained a few functional proteins similar to lipoproteins or exosomal proteins. BNHBs inhibited transforming growth factor-beta 1 (TGF-ß1)-induced fibrosis damage in human embryonic lung fibroblasts (HELFs) by inhibiting the expression of α-smooth muscle actin and collagen-1 protein. BNHBs also intensively bound TGF-ß1 to inhibit TGF-ß1 activity in fibrogenesis. BNHBs successfully reduced pulmonary inflammation and collagen deposition in a mouse model, preventing pulmonary fibrosis. Applying the protective properties of nanodiscs may be a novel therapeutic approach for pulmonary and other diseases.


Subject(s)
Blood Proteins/therapeutic use , Nanoparticles/therapeutic use , Pulmonary Fibrosis/therapy , Animals , Cell Line , Female , Humans , Metalloproteins/therapeutic use , Mice, Inbred ICR
3.
ACS Appl Mater Interfaces ; 8(48): 33165-33174, 2016 Dec 07.
Article in English | MEDLINE | ID: mdl-27934199

ABSTRACT

Antibiotics and antibiotic resistance genes (ARGs) in the natural environment have become substantial threats to the ecosystem and public health. Effective strategies to control antibiotics and ARG contaminations are emergent. A novel carbon nanomaterial, graphene oxide (GO), has attracted a substantial amount of attention in environmental fields. This study discovered the inhibition effects of GO on sulfamethoxazole (SMZ) uptake for bacteria and ARG transfer among microorganisms. GO promoted the penetration of SMZ from intracellular to extracellular environments by increasing the cell membrane permeability. In addition, the formation of a GO-SMZ complex reduced the uptake of SMZ in bacteria. Moreover, GO decreased the abundance of the sulI and intI genes by approximately 2-3 orders of magnitude, but the global bacterial activity was not obviously inhibited. A class I integron transfer experiment showed that the transfer frequency was up to 55-fold higher in the control than that of the GO-treated groups. Genetic methylation levels were not significant while sulI gene replication was inhibited. The biological properties of ARGs were altered due to the GO-ARG noncovalent combination, which was confirmed using multiple spectral analyses. This work suggests that GO can potentially be applied for controlling ARG contamination via inhibiting antibiotic uptake and ARG propagation.


Subject(s)
Acinetobacter/genetics , Alcaligenes/genetics , Graphite/pharmacology , Sulfamethoxazole/pharmacokinetics , Acinetobacter/drug effects , Acinetobacter/metabolism , Alcaligenes/drug effects , Alcaligenes/metabolism , Anti-Infective Agents/pharmacokinetics , Anti-Infective Agents/pharmacology , Cell Membrane Permeability , DNA Methylation , Drug Interactions , Drug Resistance, Microbial/genetics , Oxides/pharmacology , Plasmids/genetics , Sulfamethoxazole/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...